Belviq lawsuit claims allege that the weight-loss drug lorcaserin caused cancer in patients who took it as prescribed. The FDA requested Belviq’s removal from the market in February 2020. A major clinical trial revealed higher cancer rates among Belviq users. Thousands of patients who trusted this medication now face serious health consequences. Eisai Inc., the drug’s marketer, is the primary defendant in this litigation. If you took Belviq and were later diagnosed with cancer, you may qualify to seek compensation.
Case Timeline
Last checked: May 16, 2026
What Is the Belviq Lawsuit About?
Belviq (lorcaserin hydrochloride) was a prescription weight-loss medication. The FDA approved it in June 2012 for adults with obesity or overweight conditions. It worked by activating serotonin receptors in the brain to suppress appetite. Arena Pharmaceuticals developed the drug. Eisai Inc. later acquired global marketing rights in 2017. The drug was classified as a Schedule IV controlled substance.
However, a required post-market safety trial uncovered a disturbing cancer signal. The CAMELLIA-TIMI 61 study followed approximately 12,000 patients over five years. Results showed that 7.7% of Belviq users developed cancer. In contrast, only 7.1% of placebo patients were diagnosed with cancer. Pancreatic, colorectal, and lung cancers appeared more frequently in the Belviq group. As a result, the FDA concluded the drug’s risks outweighed any weight-loss benefits.
Belviq lawsuit plaintiffs argue that Eisai and Arena knew or should have known about cancer risks. Early animal studies had flagged tumor development before approval. Despite these warning signs, the companies marketed the drug to millions. The FDA formally requested withdrawal on February 13, 2020. Patients who developed cancer after taking Belviq are now seeking accountability through the courts.
MDL Case Status and Key Facts
| Detail | Information |
|---|---|
| MDL Number | MDL No. 3005 (denied by JPML August 2021) |
| Coordination Judge | Judge Anne C. Conway |
| Federal District | Middle District of Florida (informal coordination) |
| Case Status | Proceedings stayed for settlement negotiations |
| Bellwether Trials | None currently scheduled |
| Key Defendants | Eisai Inc., Arena Pharmaceuticals |
| Drug Withdrawal Date | February 13, 2020 |
The Belviq lawsuit litigation does not have a formal MDL. In August 2021, the U.S. Judicial Panel on Multidistrict Litigation denied consolidation under MDL No. 3005. The panel cited the small number of cases and highly individualized causation issues. Cases involve many different cancer types and varying durations of drug use. As a result, informal coordination has occurred primarily in the Middle District of Florida.
Judge Anne C. Conway oversees the key cluster of federal cases. In May 2022, she granted a stay of all proceedings. This stay allows the parties to pursue global settlement negotiations. As of May 2026, those negotiations remain ongoing. No bellwether trial dates have been set. Individual cases continue to be filed in both state and federal courts across the country.
Who Qualifies for the Belviq Lawsuit?
You might be eligible to join a Belviq lawsuit if you meet certain criteria. Typically, you must have taken Belviq or Belviq XR by prescription. Most attorneys require a minimum of six months of cumulative use. The cancer diagnosis should have occurred within seven years of Belviq use. You must also have been at least 18 years old when filing.
The strongest Belviq lawsuit claims involve specific cancer types. Colorectal cancer is the most commonly cited diagnosis. Pancreatic and lung cancers are also strongly linked to Belviq use. Some plaintiffs have filed claims based on breast cancer diagnoses. For example, at least one Florida plaintiff with breast cancer reached a settlement. The cancer must be a primary diagnosis, not a metastasis from another site.
Medical records are essential to building a strong case. You will need proof of your Belviq prescription and pharmacy records. Cancer diagnosis documentation from your oncologist is also required. In most cases, attorneys will review your records at no upfront cost. However, you should consult a licensed attorney to evaluate your specific situation. Each case depends on individual medical history and circumstances.
How to File a Belviq Lawsuit Claim
Filing a Belviq lawsuit begins with contacting an experienced mass tort attorney. Many law firms offer free case evaluations for Belviq claims. During the initial consultation, the attorney will review your drug use history. They will also assess your cancer diagnosis and treatment timeline. Most Belviq attorneys work on a contingency fee basis. This means you pay nothing unless you receive compensation.
After retaining an attorney, you will complete a plaintiff fact sheet. This document details your Belviq usage, medical history, and cancer diagnosis. Your attorney will gather supporting evidence from pharmacies and medical providers. They will then file your claim in the appropriate state or federal court. The process typically takes several weeks to initiate. Your attorney handles all legal filings and deadlines on your behalf.
The statute of limitations is a critical factor in every Belviq lawsuit. Filing deadlines vary significantly by state. Some states allow only one year from discovery of the injury. Others permit up to six years. The “discovery rule” may apply in many jurisdictions. This means the clock starts when you learned your cancer may be connected to Belviq. However, time is limited. You should contact an attorney promptly to protect your legal rights.
Settlement Updates and What to Expect
As of May 2026, no global Belviq lawsuit settlement has been publicly announced. However, individual settlements have been reached in confidential agreements. In most cases, settlement terms remain undisclosed. The litigation has been stayed since May 2022 to allow settlement negotiations. This extended stay suggests both sides are actively working toward resolution.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Several factors will influence potential Belviq lawsuit compensation. The type and severity of cancer diagnosed plays a major role. Duration of Belviq use also affects claim value. Plaintiffs with longer usage periods and more aggressive cancers typically have stronger claims. Medical expenses, lost wages, and pain and suffering are all considered. Settlement amounts vary widely based on individual circumstances.
The timeline for resolution remains uncertain. Without bellwether trials, there are no jury verdicts to establish case values. However, the ongoing stay for settlement discussions is a positive sign. Mass tort settlements of this nature can take months or years to finalize. Once a global agreement is reached, individual payouts follow a structured distribution process. Consulting a licensed attorney is the best way to understand what your specific claim might be worth.
State-by-State Considerations
State laws significantly affect Belviq lawsuit claims. Each state has different statutes of limitations for product liability cases. For example, Florida allows four years from the date of discovery. Missouri offers a five-year window. Kentucky and Louisiana provide only one year. These differences can determine whether you still have time to file. You can learn more about your state’s specific rules on our tort reform by state guide page.
Notable Belviq lawsuit activity has been reported in several states. Florida has the most documented federal cases due to Judge Conway’s coordination role. Missouri saw the first Belviq lawsuit filed in September 2020. New York, New Jersey, and California also have active filings. State tort reform laws, including damage caps and expert witness requirements, affect potential recoveries. Consulting an attorney licensed in your state is essential for understanding local rules that apply to your claim.
Frequently Asked Questions
Is it too late to file a Belviq lawsuit in 2026?
It depends on your state’s statute of limitations and when you discovered your injury. Some states have longer filing windows than others. The discovery rule may extend your deadline if you only recently connected your cancer to Belviq. However, you should consult a licensed attorney immediately to evaluate your options.
What types of cancer qualify for a Belviq lawsuit?
The most commonly accepted diagnoses are colorectal, pancreatic, and lung cancer. Some attorneys also accept breast cancer and other cancer types linked to Belviq use. The cancer must be a primary diagnosis. You should discuss your specific diagnosis with an experienced mass tort attorney.
How long does a Belviq lawsuit take to resolve?
Mass tort cases typically take several years from filing to resolution. The Belviq litigation has been in settlement negotiations since 2022. Individual timelines vary based on case complexity and court schedules. Your attorney can provide a more specific estimate based on your circumstances.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Texas Tort Reform Guide
- Georgia Tort Reform Guide
- California Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.